title: Comparison of the effects of auranofin and retinoic acid on plasminogen activator activity of peritoneal macrophages and Lewis lung carcinoma cells.
abstract: Urokinase-type plasminogen activator, a neutral proteinase, seems to play a central role in the degradation of the extracellular matrix that accompanies a number of biological phenomena including inflammatory reactions and neoplasia. The effect of auranofin and retinoic acid on the plasminogen activator activity expressed by two cell types, i.e. murine macrophages and Lewis lung carcinoma cells, has been investigated. Low concentrations of both drugs (10(-6)-10(-7) M) can inhibit in vitro the induction of plasminogen activator in macrophages stimulated by phorbol 12-myristate 13-acetate. This action occurs rapidly (15 min), is irreversible and is independent of a global cytotoxic effect. Auranofin and retinoic acid remain without effect in macrophages when added after stimulation by the phorbol ester. Both drugs are thus potent inhibitors of the induction of plasminogen activator activity in macrophages, possibly through an interaction with the protein kinase C system. The plasminogen activator activity of Lewis lung carcinoma cells, which is apparently not dependent on a protein kinase C pathway, is not influenced by auranofin or retinoic acid. These observations may contribute to explain: (1) the activity of auranofin and retinoic acid in rheumatoid arthritis, and (2) the antitumor promoting activity of retinoic acid. It would be relevant to assess whether auranofin may exhibit, like retinoic acid, an antitumor-promoting activity.
authors.affiliation: Unité de Toxicologie Industrielle et Médecine, Faculté de Médecine, Université Catholique de Louvain, Bruxelles, Belgium.
authors.forename: D
authors.initials: D
authors.lastname: Lison
authors.forename: B
authors.initials: B
authors.lastname: Knoops
authors.forename: C
authors.initials: C
authors.lastname: Collette
authors.forename: R
authors.initials: R
authors.lastname: Lauwerys
mesh_terms: D000818:Animals; D001310:Auranofin / Q000494:pharmacology*; D002460:Cell Line; D002478:Cells, Cultured; D004792:Enzyme Precursors / Q000378:metabolism*; D007700:Kinetics; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008175:Lung Neoplasms / Q000201:enzymology*; D008264:Macrophages / Q000201:enzymology*; D008668:Metallothionein / Q000378:metabolism; D051379:Mice; D010960:Plasminogen Activators / Q000378:metabolism*; D014212:Tretinoin / Q000494:pharmacology*; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism*
chemical_list: D004792:Enzyme Precursors; D001310:Auranofin; D014212:Tretinoin; D008668:Metallothionein; D007770:L-Lactate Dehydrogenase; D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator